Enhancing Endogenous Hyaluronic Acid in Osteoarthritic Joints with an Anti‐Inflammatory Supramolecular Nanofiber Hydrogel Delivering HAS2 Lentivirus

Feng Zhou,Muchao Chen,Yufan Qian,Kai Yuan,Xuequan Han,Weishan Wang,Jiong Jiong Guo,Qian Chen,Bin Li
DOI: https://doi.org/10.1002/smll.202400542
IF: 13.3
2024-04-11
Small
Abstract:Degradation of the HAS2@DexP‐Gel results in the release of the HAS2 lentivirus and DexP molecules. Transfected FLS shows increased endogenous HA production facilitated by the HAS2 lentivirus. Furthermore, DexP molecules inhibit M1 macrophages through modulation of the PI3K/AKT/mTOR/HIF‐1α pathway. Synergistic effects of HAS2@DexP‐Gel collectively suppress synovitis and delay cartilage degeneration. Osteoarthritis (OA) management remains challenging because of its intricate pathogenesis. Intra‐articular injections of drugs, such as glucocorticoids and hyaluronic acid (HA), have certain limitations, including the risk of joint infection, pain, and swelling. Hydrogel‐based therapeutic strategies have attracted considerable attention because of their enormous therapeutic potential. Herein, a supramolecular nanofiber hydrogel is developed using dexamethasone sodium phosphate (DexP) as a vector to deliver lentivirus‐encoding hyaluronan synthase 2 (HAS2) (HAS2@DexP‐Gel). During hydrogel degradation, HAS2 lentivirus and DexP molecules are slowly released. Intra‐articular injection of HAS2@DexP‐Gel promotes endogenous HA production and suppresses synovial inflammation. Additionally, HAS2@DexP‐Gel reduces subchondral bone resorption in the anterior cruciate ligament transection‐induced OA mice, attenuates cartilage degeneration, and delays OA progression. HAS2@DexP‐Gel exhibited good biocompatibility both in vitro and in vivo. The therapeutic mechanisms of the HAS2@DexP‐Gel are investigated using single‐cell RNA sequencing. HAS2@DexP‐Gel optimizes the microenvironment of the synovial tissue by modulating the proportion of synovial cell subpopulations and regulating the interactions between synovial fibroblasts and macrophages. The innovative nanofiber hydrogel, HAS2@DexP‐Gel, effectively enhances endogenous HA production while reducing synovial inflammation. This comprehensive approach holds promise for improving joint function, alleviating pain, and slowing OA progression, thereby providing significant benefits to patients.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?